MLEC Stock Overview
A science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 0/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
Moolec Science SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$0.87 |
52 Week High | US$3.27 |
52 Week Low | US$0.77 |
Beta | -0.55 |
11 Month Change | -4.91% |
3 Month Change | -26.26% |
1 Year Change | -73.39% |
33 Year Change | -91.12% |
5 Year Change | n/a |
Change since IPO | -91.13% |
Recent News & Updates
Is Moolec Science (NASDAQ:MLEC) Using Too Much Debt?
Aug 06Is Moolec Science (NASDAQ:MLEC) A Risky Investment?
Apr 22Shareholder Returns
MLEC | US Food | US Market | |
---|---|---|---|
7D | -0.2% | 0.3% | 0.07% |
1Y | -73.4% | 1.5% | 22.7% |
Return vs Industry: MLEC underperformed the US Food industry which returned 1.5% over the past year.
Return vs Market: MLEC underperformed the US Market which returned 22.7% over the past year.
Price Volatility
MLEC volatility | |
---|---|
MLEC Average Weekly Movement | 8.7% |
Food Industry Average Movement | 4.9% |
Market Average Movement | 6.3% |
10% most volatile stocks in US Market | 15.0% |
10% least volatile stocks in US Market | 3.1% |
Stable Share Price: MLEC's share price has been volatile over the past 3 months.
Volatility Over Time: MLEC's weekly volatility has decreased from 16% to 9% over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2020 | 45 | Gaston Paladini | moolecscience.com |
Moolec Science SA, a science-based food ingredient company, focuses on developing real animal proteins in plants using molecular farming. It offers Chymosin SPC, a dairy ingredient; GLA SONOVA, a nutritional oil; POORK+, a plant-based, animal meat free ingredient with porcine proteins in soybeans; and BEEF+, a meat replacement product. It operates in the United States, Europe, and South America.
Moolec Science SA Fundamentals Summary
MLEC fundamental statistics | |
---|---|
Market cap | US$32.68m |
Earnings (TTM) | -US$7.52m |
Revenue (TTM) | US$5.01m |
6.5x
P/S Ratio-4.3x
P/E RatioIs MLEC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
MLEC income statement (TTM) | |
---|---|
Revenue | US$5.01m |
Cost of Revenue | US$4.61m |
Gross Profit | US$400.92k |
Other Expenses | US$7.93m |
Earnings | -US$7.52m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.20 |
Gross Margin | 8.01% |
Net Profit Margin | -150.28% |
Debt/Equity Ratio | 202.3% |
How did MLEC perform over the long term?
See historical performance and comparison